RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Targeting histone deacetylase in thyroid cancer
2013-01-01 Russo, D; Durante, C; Bulotta, S; Puppin, C; Puxeddu, E; Filetti, S; Damante, G
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer
2018-01-01 Celano, M; Mio, C; Sponziello, M; Verrienti, A; Bulotta, S; Durante, C; Damante, G; Russo, D.
Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes.
2014-01-01 Cosco, D; Celano, M.; Wolfram, J.; Voce, P.; Puxeddu, E.; Filetti, S.; Celia, C.; Ferrari, M.; Paolino, D; Gaspari, M; Russo, D; Fresta, M
The 3',5'-Cyclic Adenosine Monophosphate Response Element Binding Protein (CREB) Is Functionally Reduced in Human Toxic Thyroid Adenomas
2000-01-01 Brunetti, A; Chiefari, E.; Filetti, S.; Russo, D.
The biological activity of bovine and human thyrotropin is differently affected by trypsin treatment of human thyroid cells: thyroid stimulating antibody is related to human thyrotropin
1991-01-01 Foti, D.; Filetti, S; Costante, G; Russo, D
The cyclic AMP response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas
2000-01-01 Brunetti, A; Chiefari, E; Filetti, S; Russo, D.
The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells.
2019-01-01 Allegri, L; Baldan, F; Roy, S; Aubé, J; Russo, D; Filetti, S; Damante, G.
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines.
2013-01-01 Lavarone, E; Puppin, C; Passon, N; Filetti, S; Russo, D; Damante, G.
The role of diet on insulin sensitivity
2020-01-01 Mirabelli, M.; Russo, D.; Brunetti, A.
Thyroid hyperfunctioning adenomas with and without Gsp/TSH receptor mutations show similar clinical features.
1998-01-01 Capula, C; Chiefari, E; Filetti, S; Russo, D.; Arturi, F
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 260
- 1 Contributo su Rivista::1.1 Arti... 235
- 1 Contributo su Rivista::1.5 Abst... 24
- 1 Contributo su Rivista::1.2 Rece... 1
Data di pubblicazione
- 2020 - 2024 17
- 2010 - 2019 84
- 2000 - 2009 95
- 1990 - 1999 62
- 1989 - 1989 2
Editore
- Frontiers Media S.A. 1
Rivista
- JOURNAL OF ENDOCRINOLOGICAL INVES... 25
- THE JOURNAL OF CLINICAL ENDOCRINO... 23
- JOURNAL OF ENDOCRINOLOGICAL INVES... 18
- THYROID 18
- ENDOCRINOLOGY 16
- EUROPEAN JOURNAL OF ENDOCRINOLOGY 13
- MOLECULAR AND CELLULAR ENDOCRINOLOGY 11
- ENDOCRINE 9
- BMC CANCER 7
- ENDOCRINE 6
Keyword
- radioiodine 3
- thyroid cancer 3
- Gemcitabine 2
- JQ1 2
- Lipoamino acids 2
- Liposomes 2
- paclitaxel 2
- Thyroid cancer 2
- 4 1
- acquired resistance 1
Lingua
- eng 211
Accesso al fulltext
- no fulltext 259
- reserved 1